Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis

Pediatric and Developmental Pathology

Volumn 15, Issue 3, 2012, Pages 173-178

  Bo, Ning ^a   Wang, Dahui ^a   Wu, Bingbing ^b   Chen, Lian ^a   Ma, Ruixue ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

catenin; Aggressive fibromatosis; Mutation; Pediatric

Indexed keywords

BETA CATENIN;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; FIBROMATOSIS; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR RECURRENCE;

ADOLESCENT; BETA CATENIN; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84865228719     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-07-0866-OA.1     Document Type: Article

References (34)

1. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002;83-84.
2. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT III. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 2000;88:1517-1523. (Pubitemid 30183134)
3. Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665-673. (Pubitemid 12073161)
4. Weiss SW, Goldblum, JR, eds. Enzinger and Weiss's Soft Tissue Tumors, 4th ed. St Louis: Mosby, 2001;309-346.
5. Bandipalliam P. Desmoid tumors and familial adenomatous polyposis: a tale of two syndromes. J Clin Gastroenterol 2007;41:231-236. (Pubitemid 46340742)
6. Ferenc T, Sygut J, Kopczynski J, et al. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol 2006;57:5-15. (Pubitemid 43886163)
7. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-398. (Pubitemid 43381685)
8. Gebert C, Hardes J, Kersting C, et al. Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis. Histopathology 2007;50:491-497. (Pubitemid 46328180)
9. Lopez R, Kemalyan N, Moseley HS, Dennis D, Vetto RM. Problems in diagnosis and management of desmoid tumors. Am J Surg 1990;159:450-453. (Pubitemid 20160997)
10. Amary MF, Pauwels P, Meulemans E, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol 2007;31:1299-1309. (Pubitemid 47329665)
11. Camuesco D, Peran L, Comalada M, et al. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis 2005;11:265-271. (Pubitemid 40439681)
12. Jilong Y, Jian W, Xiaoyan Z, Xiaoqiu L, Xiongzeng Z. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Pathology 2007;39:319-325. (Pubitemid 46897606)
13. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol 2009;35:3-10.
14. Miyaki M, Yamaguchi T, Iijima T, et al. Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype. Int J Cancer 2008;122:2491-2497. (Pubitemid 351590481)
15. Saito T, Oda Y, Kawaguchi K, et al. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest 2002;82:97-103. (Pubitemid 34072650)
16. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
17. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003;94:225-229. (Pubitemid 36575886)
18. Denys H, Jadidizadeh A, Amini Nik S, et al. Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors. Oncogene 2004;23:654-664. (Pubitemid 38258214)
19. Mosimann C, Hausmann G, Basler K. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 2006;125:327-341. (Pubitemid 44313810)
20. Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006;16:51-59. (Pubitemid 43089612)
21. Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev 2004;18:2225-2230. (Pubitemid 39209569)
22. Harris TJ, Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol 2005;15:234-237. (Pubitemid 40603891)
23. Huber AH, Weis WI. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 2001;105:391-402. (Pubitemid 32455345)
24. Park SY, Kim BH, Kim JH, et al. Methylation profiles of CpG island loci in major types of human cancers. J Korean Med Sci 2007;22:311-317.
25. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119. (Pubitemid 121001351)
26. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-185. (Pubitemid 21909684)
27. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509-514. (Pubitemid 47437826)
28. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008;173:1518-1527.
29. Nero CJ, Lazar AJ, Lev D, Pappo AS, Lopez-Terrada D. Role of the Wnt/6-catenin pathway in pediatric desmoid tumors. Presented at SPP meeting 2010.
30. Thway K, Gibson S, Ramsay A, Sebire NJ. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases. Pediatr Dev Pathol 2009;12:292-296.
31. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653-659. (Pubitemid 40577876)
32. Montgomery E, Folpe AL. The diagnostic value of beta-catenin immunohistochemistry. Adv Anat Pathol 2005;12:350-356.
33. Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM, Wu TT. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002;33:39-46. (Pubitemid 34112951)
34. Saito T, Oda Y, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y, Tsuneyoshi M. Beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours. J Pathol 2001;195:222-228. (Pubitemid 32899032)